Market Research Report
Bioreactor Market Size By Cell, By Molecule, By Technology, By End-Use Industry Analysis Report, Regional Outlook, Application Development, Price Trend, Competitive Landscape & Forecast, 2017 - 2024
|Published by||Global Market Insights Inc.||Product code||555449|
|Published||Content info||100 Pages
Delivery time: 1-2 business days
|Bioreactor Market Size By Cell, By Molecule, By Technology, By End-Use Industry Analysis Report, Regional Outlook, Application Development, Price Trend, Competitive Landscape & Forecast, 2017 - 2024|
|Published: May 10, 2017||Content info: 100 Pages||
Bioreactors Market to exceed USD 1.9 billion by 2024 as per a new research report.
Rising prevalence of chronic diseases stimulating demand for personalized medicines and orphan drugs will act as primary drivers for bioreactors market. Increasing investment for R&D activities in biologics industry coupled with growing demand for biopharmaceuticals will fuel bioreactors market growth over the forecast period.
Technological advancements such as single-use bioreactor technology and development of personalized medicines involving several clinical trials and bioprocesses will propel market growth. Concerns related to disposables and leachable coupled with low capacity of single-use bioreactors will hinder bioreactor market growth over the coming years.
Bacterial cells market should grow at lucrative rate due to rising demand for advanced antibiotics, increasing prevalence of food borne diseases and growth of food microbiology sector. Rising adoption of immobilized bacterial bioreactors in small manufacturing plant and commercial laboratories will fuel business growth.
Monoclonal antibodies market will witness significant growth during the forecast period due to increasing therapeutic application of monoclonal antibodies in asthma, breast cancers, rheumatoid arthritis, psoriasis, leukemia, chronic gastrointestinal inflammatory disease, and transplant rejection treatment. Monoclonal antibodies possess extended half-life, reduced toxicity and superior specificity thereby increasing demand over the coming years.
Single-use bubble column market will grow considerably over the forecast period owing to rising demand for single-use bubble column reactor in biotechnology industry. Automation, compactness, high mass transfer and heat transfer rates coupled with low operational and maintenance requirement will fuel product demand.
Contract manufacturing organizations (CMO's) market will exhibit lucrative growth over the forecast period due to rising number of contract manufacturing organizations and growing demand for biopharmaceuticals. Rising trend in pharmaceutical industry towards outsourcing clinical trials and other such functions to CMO's to reduce regulatory burden and cost will favor industry growth.
U.S. bioreactors market should grow at a significant CAGR over the forecast period. Increasing investment in R&D pertaining to biopharmaceuticals and growing adoption of single-use products will drive U.S. bioreactors market. Rising demand for personalized medicines and technological advancements in products will positively impact market growth.
High growth of biotechnology industry along with initiation of programs such as 'The National Biotechnology Program' will drive Brazil bioreactors market over the forecast period. Strategic collaboration between pharmaceutical companies and research organizations, universities will favor business growth.
South Africa bioreactors market will be driven by rising prevalence of chronic diseases stimulating demand for personalized medicines, growing adoption of biopharmaceutical products and increased investment for healthcare infrastructure development. Favorable government policies to support growth of biotechnology industry will favor regional growth.
Few notable industry players include GE Healthcare, Sartorius, Thermo Fisher Scientific, Eppendorf, and Merck Millipore. Strategic alliances, merger and acquisitions are key strategies followed by market players to strengthen their product portfolio and position in the market.